Framework for use of toxicity screening tools in context-based decision-making

Food and Chemical Toxicology

Volumn 45, Issue 5, 2007, Pages 759-796

  Doull, John ^a   Borzelleca, Joseph F ^b   Becker, Richard ^c   Daston, George ^d   DeSesso, John ^e   Fan, Anna ^f   Fenner Crisp, Penelope ^g   Holsapple, Michael ^h   Holson, Joseph ⁱ   Craig Llewellyn, G ^j   MacGregor, James ^k   Seed, Jennifer ^l   Walls, Isabel ^g   Woo, Yin tak ^l   Olin, Stephen ^g  

^a UNIVERSITY OF KANSAS   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c AMERICAN CHEMISTRY COUNCIL   (United States)

^d PROCTER AND GAMBLE COMPANY   (United States)

^e NOBLIS   (United States)

^f CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

^g International Life Sciences Institute   (United States)

^h ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

ⁱ WIL RESEARCH LABORATORIES   (United States)

^j Kraft Foods   (United States)

^k CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^l U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

more..

Author keywords

Carcinogenicity; Decision tree; Endocrine disruptor; Immunotoxicity; Structure activity relationships; Toxicity testing

Indexed keywords

ARTICLE; DATA ANALYSIS; DECISION MAKING; RISK ASSESSMENT; RISK MANAGEMENT; SCREENING TEST; TOXICITY TESTING;

ANIMALS; DECISION MAKING; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; HUMANS; RISK ASSESSMENT; RISK MANAGEMENT; UNITED STATES;

EID: 33947398415     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.10.025     Document Type: Article

References (193)

1. Aardema M.J., and MacGregor J.T. Toxicology and genetic toxicology in the new era of toxicogenomics: Impact of -omics technologies. Mutat. Res. 499 (2002) 13-25
2. Allen B.C., Crump K.S., and Shipp A.M. Correlation between carcinogenic potency of chemicals in animals and humans. Risk Anal. 8 4 (1988) 531-544
3. Anderson N.L., Matheson A.D., and Steiner S. Proteomics: Applications in basic and applied biology. Curr. Opin. Biotechnol. 11 (2000) 408-412
4. Anisimov V.N. Ageing and the mechanisms of carcinogenesis: some practical implications. J. Exp. Clin. Cancer Res. 17 (1998) 263-268
5. Ashby J., and Paton D. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures. Mutat. Res. 286 1 (1993) 3-74
6. Ashby J., and Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the US NTP. Mutat. Res. 257 (1991) 229-306
7. ATSDR, 1999. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Chlorophenols. PB/99/166639, Atlanta, GA.
8. Barber E.D., Donish W.H., and Mueller K.R. A procedure for the quantitative measurement of volatile liquids in the Ames Salmonella/microsome assay. Mutat. Res 90 (1981) 31-48
9. Bartsch H., and Malaveille C. Screening assays for carcinogenic agents and mixtures: an appraisal based on data in the IARC Monograph series. IARC Sci. Publ. 104 (1990) 65-74
10. Basketter D.A., Gerberick G.F., Kimber I., and Loveless S.E. The local lymph node assay: viable alternative to currently accepted skin sensitization tests. Food Chem. Toxicol. 34 (1996) 985-997
11. Begley T.H. Methods and approaches used by the FDA to evaluate the safety of food packaging materials. Food Add. Contam. 14 6-7 (1997) 545-553
12. Benigni R., and Giuliani A. Tumor profiles and carcinogenic potency in rodents and humans: Values for cancer risk assessment. Environ. Carcinogenesis Ecotoxicol. Rev. - Part C of Environ. Sci. Health 17 1 (1999) 45-67
13. Benigni R., and Giuliani A. Putting the predictive toxicology challenge into perspective: reflections on the results. Bioinformatics 19 (2003) 1194-1200
14. Benigni R., and Passerini L. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment. Mutat. Res. 511 (2002) 191-206
15. Benigni R., and Zito R. The second National Toxicology Program comparative exercise on the prediction of rodent carcinogenicity: definitive results. Mutat. Res. 566 1 (2004) 49-63
16. Bichsel V.E., Liotta L.A., and Petricoin III E.F. Cancer proteomics: From biomarker discovery to signal pathway profiling. Cancer J. 7 (2001) 69-78
17. Biomarkers Definitions Working Group. Biomarkers and surrogate end- points: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69 (2001) 89-95
18. Blackburn K., Stickney J.A., Carlson-Lynch H.L., McGinnis P.M., Chappell L., and Felter S.P. Application of the threshold of toxicological concern approach to ingredients in personal and household care products. Regul. Toxicol. Pharmacol. 43 3 (2005) 249-259
19. Boutwell R.K., and Bosch D.K. The tumor-promoting action of phenol and related compounds for mouse skin. Cancer Res. 19 (1959) 413-424
20. Brennan R.J., and Schiestl R.H. Chloroform and carbon tetrachloride induce intrachromosomal recombination and oxidative free radicals in Saccharomyces cerevisiae. Mutat Res. 397 2 (1998) 271-278
21. Brimer P.A., Tan E.L., and Hsie A.W. Effect of metabolic activation on the cytotoxicity and mutagenicity of 1,2-dibromoethane in the CHO/HGPRT system. Mutat. Res. 95 (1982) 377-388
22. Bucher J.R., and Portier C. Human carcinogenic risk evaluation, Part V: The national toxicology program vision for assessing the human carcinogenic hazard of chemicals. Toxicol. Sci. 82 2 (2004) 363-366
23. Butterworth B.E. Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutat. Res. 239 (1990) 117-132
24. Cahill D.J. Protein and antibody arrays and their medical applications. J. Immunol. Methods 250 (2001) 81-91
25. Carere A., and Morpurgo G. Comparison of the mutagenic activity of pesticides in vitro in various short term assays. Prog. Mutat. Res. 2 (1981) 87-104
26. Clayson D.B., and Kitchin K.T. Interspecies differences in response to chemical carcinogens. In: Kitchin K.T. (Ed). Carcinogenicity. Testing, Predicting, and Interpreting Chemical Effects (1999), Marcel Dekker Inc., New York 837-880
27. Colacci A., Bartoli S., Bonora B., Guidotti L., Lattanzi G., Mazzullo M., Niero A., Perocco P., Silingardi P., and Grilli S. Chloroform bioactivation leading to nucleic acids binding. Tumori 77 4 (1991) 285-290
28. COT (United Kingdom Food Standards Agency, Committee on Toxicity), 2003, Annual Report 2002. Available from: .
29. Cronin M.T.D., Jaworska J.S., Walker J.D., Comber M.H.I., Watts C.D., and Worth A.P. Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environ. Health Persp. 111 (2003) 1391-1401
30. Davies T.S., Lynch B.S., Monro A.M., Munro I.C., and Nestman E.R. Rodent carcinogenicity tests need be no longer than 18 months: an analysis based on 210 chemicals in the IARC monographs. Food Chem. Toxicol. 38 (2000) 219-235
31. Dearman R.J., Betts C.J., Humphreys N., Flanagan B.F., Gilmour N.J., Basketter D.A., and Kimber I. Chemical allergy: considerations for the practical application of cytokine profiling. Toxicol. Sci. 71 2 (2003) 137-145
32. Duchin K.L., McKinstry D.N., Cohen A.I., and Migdalof B.H. Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases. Clin. Pharmacokinet. 14 4 (1988) 241-259
33. Eastin W.C., Mennear J.H., Tennant R.W., Stoll R.E., Branstetter D.G., Bucher J.R., McCullough B., Binder R.L., Spalding J.W., and Mahler J.F. Tg.AC genetically altered mouse: assay working group overview of available data. Toxicol. Pathol. 29 Suppl. (2001) 60-80
34. EDSTAC, 1998. Endocrine Disruptor Screening and Testing Advisory Committee Final Report. Available from: .
35. Eriksson L., Jaworska J., Worth A.P., Cronin M.T.D., McDowell R.M., and Gramatica P. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ. Health Persp. 111 (2003) 1361-1375
36. Fan A.M., and Howd R. Quantitative Risk Assessment of Non-genotoxic Carcinogens. In: Choy W.N. (Ed). Genetic Toxicology and Cancer Risk Assessment (2001), Marcel Dekker, New York 299-320
37. FAO/WHO, 2001. Evaluation of Allergenicity of Genetically Modified Foods. Available from: .
38. Faustman E.M., and Omenn G.S. Risk Assessment. In: Klaassen C.D. (Ed). Casarett and Doull's Toxicology. The Basic Science of Poisons. 6th ed. (2001), McGraw-Hill, San Francisco 83-104
39. Fielden M.R., and Zacharewski T.R. Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. Toxicol. Sci. 60 (2001) 6-10
40. Franke R., and Gruska A. General introduction to QSAR. In: Benigni R. (Ed). Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens (2003), CRC Press 1-40
41. French J., Storer R.D., and Donehower L.A. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens. Toxicol. Pathol. 29 Suppl. (2001) 24-29
42. Fujie K., Aoki T., and Wada M. Acute and subacute cytogenetic effects of the trihalomethanes on rat bone marrow cells in vivo. Mutat. Res. 242 2 (1990) 111-119
43. Fujii K. Evaluation of the newborn mouse model for chemical tumorigenesis. Carcinogenesis 12 8 (1991) 1409-1415
44. Gaylord D.W., Kodell R.L., Chen J.J., and Krewski D. A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty factors. Regul. Toxicol. Pharmacol. 29 (1999) 151-157
45. Gerberick G.F., House R.V., Fletcher E.R., and Ryan C.A. Examination of the local lymph node assay for use in contact sensitizer risk assessment. Fundam. Appl. Toxicol. 19 (1992) 438-445
46. Gerberick G.F., Robinson M.K., Ryan C.A., Dearman R.J., Kimber I., Basketter D.A., Wright Z., and Marks J.G. Contact allergenic potency: correlation of human and local lymph node assay data. Am. J. Contact. Dermat. 12 3 (2001) 156-161
47. Gerberick G.F., Cruse L.W., Ryan C.A., Hulette B.C., Chaney J.G., Skinner R.A., Dearman R.J., and Kimber I. Use of a B cell marker (B220) to discriminate between allergens and irritants in the local lymph node assay. Toxicol. Sci. 68 2 (2002) 420-428
48. Gold L.S., and Slone T.H. Prediction of carcinogenicity from two versus four sex-species groups in the carcinogenic potency database. J. Toxicol. Environ. Health 39 (1993) 143-157
49. Greene N. Computer systems for the prediction of toxicity: an update. Dv. Drug Delivery Rev. 54 (2002) 417-431
50. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., James P.D., and Mangham C.M. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
51. Haseman J.K. Using the NTP database to assess the value of rodent carcinogenicity studies for determining human cancer risk. Drug Metabolism Rev. 32 2 (2000) 169-186
52. Haseman J.K., and Huff J.E. Species correlation in long term carcinogenicity studies. Cancer Lett. 37 (1987) 125-132
53. Haseman J.K., and Lockhart A.M. Correlations between chemically related site-specific carcinogenic effects in long-term studies in rats and mice. Environ. Health Persp. 101 (1993) 50-54
54. Haseman J., Melnick R., Tomatis L., and Huff J. Carcinogenesis bioassays: Study duration and biological relevance. Food Chem. Toxicol. 39 7 (2001) 739-744
55. Hefle S.L., Nordlee J.A., and Taylor S.L. Allergenic Foods. Critical Rev. Food Sci. Nutri. 36 S (1996) S69-S89
56. Helma C., and Kramer S. A survey of the Predictive Toxicology Challenge 2000-2001. Bioinformatics 19 (2003) 1179-1182
57. Hoke H., and Zellerhoff R. Metabolism and toxicity of diiospropylnaphthalene as compared to naphthalene and monoalkyl naphthalenes: a minireview. Toxicology 126 (1998) 1-7
58. Honda T., Kiyozumi, and Kojima S. Alkylnaphthalene. XI. Pulmonary toxicity of naphthalene, 2-methylnaphthalene, and isopropylnaphthalenes in mice. Chem. Pharm. Bull. (Tokyo) 38 11 (1990) 3130-3135
59. Huang R.-P., Huang R., Fan Y., and Lin Y. Simultaneous detection of multiple cytokines from conditioned media and patients sera by an antibody-based protein array system. Anal. Biochem. 294 (2001) 55-62
60. Huff J.E. Chemicals and cancer in humans. First evidence in experimental animals. Environ. Health Perspect. 100 (1993) 201-210
61. Huff J.E. Chemicals causally associated with cancers in humans and in laboratory studies. A perfect concordance. In: Waalkes M.P., and Ward J.M. (Eds). Carcinogenesis (1994), Ravens Press, New York 25-37
62. Huff J.E. Value, Validity and Historical Development of Carcinogenesis Studies for Predicting and Confirming Carcinogenic Risks to Humans 21-123. In: Kitchin K.T. (Ed). Carcinogenicity. Testing, predicting, and interpreting chemical effects (1999), Marcel Dekker, Inc., New York
63. Huff J., Cirvello J., Haseman J., and Bucher J. Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ. Health Perspect. 93 (1991) 247-270
64. Hulzebos, E.M., Janssen, P.A.H., Malankiewicz, L., Meijerink, M.C.M., Muller, J.J.A., Pelgrom, S.M.G., Verdam, L. Vermeire, T.G. 2001. The Application of Structure-Activity Relationships in Human Hazard Assessment: a First Approach. RIVM Report 601516 008, Rijksinstituut voor volksgezondheid en milieu, BA Bilthoven, The Netherlands.
65. Humphreys N.E., Dearman R.J., and Kimber I. Assessment of cumulative allergen-activated lymph node cell proliferation using flow cytometry. Toxicol. Sci. 73 1 (2003) 80-89
66. IARC, 1999. Quantitative Estimation and Prediction of Human Cancer Risks. In: Moolgavkar, S., Krewski, D., Zeise, L., Cardis, E., Moller, H., (Eds.), IARC Scientific Publication No. 131. International Agency for Research on Cancer. Lyon, France.
67. ICCVAM, 1999. The murine local lymph node assay: A test method for assessing the allergenic contact dermatitis potential of chemicals/compounds. Interagency Coordinating Committee on the Validation of Alternative Methods. National Toxicology Program. National Institutes of Health. Department of Health and Human Services. NIH Publication No. 99-4494.
68. ICH, 1997a. International Conference on Harmonization. ICH harmonized Tripartite Guideline. Genotoxicity: A standard battery for genotoxicity testing of pharmaceuticals S2B. Geneva, Switzerland.
69. ICH, 1997b. In: International Conference on Harmonization. ICH harmonized Tripartite Guideline. Testing for Carcinogenicity of Pharmaceuticals S1B. Geneva, Switzerland.
70. ILSI, 1997. An evaluation of US EPA's proposed guidelines for carcinogen risk assessment using chloroform and dichloroacetate as case studies: Report of an expert panel. International Life Sciences Institute, Health and Environmental Sciences Institute.
71. ILSI International Food Biotechnology Committee, 2004. Nutritional and Safety Assessments of Foods and Feeds Nutritionally Improved through Biotechnology. Comprehensive Reviews in Food Science and Food Safety. Available from: .
72. In: Inoue T., and Pennie W.D. (Eds). Toxicogenomics (2003), Springer-Verlag, Tokyo 171-193
73. International Programme On Chemical Safety (IPCS), 1996. Principles And Methods For Assessing Direct Immunotoxicity Associated With Exposure To Chemicals. World Health Organization Geneva, Switzerland. Available from: .
74. Ito N., Tsuda H., Tatematsu M., Inoue T., Tagawa Y., Aoki T., Uwagawa S., Kagawa M., Ogiso T., Masui T., et al. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats-an approach for a new medium-term bioassay system. Carcinogenesis 9 3 (1988) 387-394
75. Ito N., Imaida K., Tsuda H., Shibata M., Aoki T., de Camargo J.L., and Fukushima S. Wide-spectrum initiation models: possible applications to medium-term multiple organ bioassays for carcinogenesis modifiers. Jpn. J Cancer Res. 79 4 (1988) 413-417
76. Ito N., Imaida K., de Camargo J.L., Takahashi S., Asamoto M., and Tsuda H. A new medium-term bioassay system for detection of environmental carcinogens using diethylnitrosamine-initiated rat liver followed by D-galactosamine treatment and partial hepatectomy. Jpn. J Cancer Res. 79 5 (1988) 573-575
77. Ito N., Shirai T., and Hasegawa R. Medium-term bioassays for carcinogens. IARC Sci. Publ. 116 (1992) 353-388
78. Ito N., Hasegawa R., Imaida K., Takahashi S., and Shirai T. Medium-term rat liver bioassay for rapid detection of carcinogens and modifiers of hepatocarcinogenesis. Drug Metab. Rev. 26 1-2 (1994) 431-442
79. Ito N., Hasegawa R., Imaida K., Hirose M., and Shirai T. Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents. Exp. Toxicol. Pathol. 48 2-3 (1996) 113-119
80. Ito N., Imaida K., Tamano S., Hagiwara A., and Shirai T. Medium-term bioassays as alternative carcinogenicity test. J. Toxicol. Sci. 23 Suppl. 2 (1998) 103-106
81. Ito N., Imaida K., Hirose M., and Shirai T. Medium-term bioassays for carcinogenicity of chemical mixtures. Environ. Health Perspect. 106 Suppl. 6 (1998) 1331-1336
82. Ito N., Imaida K., Asamoto M., and Shirai T. Early detection of carcinogenic substances and modifiers in rats. Mutat. Res. 462 2-3 (2000) 209-217
83. Ito N., Tamano S., and Shirai T. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci. 94 1 (2003) 3-8
84. Jackson E.K. Chapter 31 Renin and Angiotensin. In: Hardman J.G., and Limbird L.E. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics (2001), McGraw Hill, New York 821-822
85. JECFA, 2005. Joint FAO/WHO Expert Committee on Food Additives. Sixty-fifth Meeting. Summary and Conclusions. www.who.int/ipcs/food/jecfa/summaries/summary65.pdf (Accessed on June 7-16, 2005).
86. Kale P., and Baum J.W. Sensitivity of Drosophila melanogaster to low concentrations of the gaseous 1,2-dibromoethane: I. Acute exposures. Environ. Mutagen 1 (1979) 15-18
87. Kale P.G., and Baum J.W. Sensitivity of Drosophila melanogaster to low concentrations of gaseous mutagens. 4. Mutations in embryonic spermatogonia. Mutat. Res. 113 (1983) 135-144
88. Kimber I., Hilton J., Dearman R.J., Gerberick G.F., Ryan C.A., Basketter D.A., Scholes E.W., Ladics G.S., Loveless S.E., House R.V., and Guy A. An international evaluation of the murine local lymph node assay and comparison of modified procedures. Toxicology 103 (1995) 63-73
89. Kimber I., Hilton J., Dearman R.J., Gerberick G.F., Ryan C.A., Basketter D.A., Lea L., House R.V., Ladics G.S., Loveless S.E., and Hastings K.L. Assessment of the skin sensitization potential of topical medicants using the local lymph node assay: an international evaluation. J. Toxicol. Environ. Health Part A 53 (1998) 563-579
90. Kimber I., Dearman R.J., Basketter D.A., Ryan C.A., and Gerberick G.F. The local lymph node assay: past, present and future. Contact Dermatitis 47 6 (2002) 315-328
91. Kirkland D., Aardema M., Henderson L., and Muller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat. Res. 584 1-2 (2005) 1-256
92. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate Jr. M., Kirchner S., Lorge E., Morita T., Norppa H., Surralles J., Vanhauwaert A., and Wakata A. Report from the in vitro micronucleus assay working group. Mutat. Res. 540 2 (2003) 153-163
93. Klaunig J.E., Babich M.A., Baetcke K.P., Cook J.C., Corton J.C., David R.M., DeLuca J.G., Lai D.Y., McKee R.H., Peters J.M., Roberts R.A., and Fenner-Crisp P.A. PPAR alpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol. 33 6 (2003) 655-780
94. Kojima S., Nakagawa M., Suzuki R., Horio M., and Tanaka Y. Alkylnaphthalenes. I. Absorption, tissue distribution and excretion of 2,6-diiospropylnaphthalene in rats. Chem. Pharm. Bull. (Tokyo) 26 10 (1978) 3007-3009
95. Kojima S., Honda T., Nakagawa M., Kiyozumi M., and Takadate A. Urinary metabolites of 2,6-diiospropylnaphthalene in rats. Drug Metab. Dispos. 10 4 (1982) 429-433
96. Kojima S., Honda T., and Kiyozumi M. Biliary metabolites of 2,6-diiospropylnaphthalene in rats. Bull. Environ. Contam. Toxicol. 35 6 (1985) 745-749
97. Kojima S., Tanaka M., and Yoshida T. Studies on the sequence of 2,6-diiospropylnaphthalene metabolite formation using carp hepatocyte. Ecotoxicol. Environ. Saf. 9 3 (1985) 364-368
98. Kroes R., and Kozianowski G. Threshold of toxicological concern (TTC) in food safety assessment. Toxicol. Lett. 127 1-3 (2002) 43-46
99. Kroes R., Galli C., Munro I., Schilter B., Tran L., Walker R., and Wurtzen G. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. Food Chem. Toxicol. 38 2-3 (2000) 255-312
100. Kroes R., Renwick A., Cheeseman M., Kleiner J., Mangelsdorf I., Piersma A., Schilter G., Schlatter J., vam Schothorst F., Vos J.G., and Wurtzen G. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem. Toxicol. 42 1 (2004) 65-83 European branch of the International Life Sciences Institute
101. Kroes R., Kleiner J., and Renwick A. The threshold of toxicological concern concept in risk assessment. Toxicol. Sci. 86 2 (2005) 226-230
102. Lai D.Y., Baetcke K.P., Vu V.T., Cotruvo J.A., and Eustis S.L. Evaluation of reduced protocols for carcinogenicity testing of chemicals: Report of a joint EPA/NIEHA workshop. Regul. Toxicol. Pharmacol. 19 (1994) 183-201
103. Levin B., Brooks D., Smith R.A., and Stone A. Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J. Clin. 53 1 (2003) 44-55
104. Lindahl T., and Wood R.D. Quality control by DNA repair. Science 286 (1999) 1897-1905
105. Llewellyn G.C., Lockwood J.F., and Wierda D. Evaluation of transdermally-delivered drugs using the local lymph node assay. The Toxicol. 48 (1999) 802
106. Loveless S.E., Ladics G.S., Gerberick G.F., Ryan C.A., Basketter D.A., Scholes E.W., House R.V., Hilton J., Dearman R.J., and Kimber I. Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology 108 (1996) 141-152
107. MacGregor J.T. The future of regulatory toxicology: impact of the biotechnology revolution. Toxicol. Sci. 75 (2003) 236-248
108. MacGregor J.T., Farr S., Tucker J.D., Heddle J.A., Tice R.R., and Turteltaub K.W. New molecular endpoints and methods for routine toxicity testing. Fund. Appl. Toxicol. 26 (1995) 156-173
109. Macri J.N., and Weiss R.R. Prenatal serum alpha-fetoprotein screening for neural tube defects. Obstet Gynecol. 59 (1982) 633-639
110. Maltoni C., Soffritti M., and Belpoggi F. The scientific and methodological basis of experimental studies for detecting and quantifying carcinogenic risks. Ann. New York Acad. Sci. 895 (1999) 10-26
111. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., and Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N. Engl. J. Med. 328 (1993) 1365-1371
112. McClain R.M., Keller D., Casciano D., Fu P., MacDonald J., Popp J., and Sagartz J. Neonatal mouse model: review of methods and results. Toxicol. Pathol. 29 Suppl (2001) 128-137
113. Meek M.E., Bucher J.R., Cohen S.M., Dellarco V., Hill R.N., Lehman-McKeeman L.D., Longfellow D.G., Pastoor T., Seed J., and Patton D.E. A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol. 33 6 (2003) 591-653
114. Metcalfe D.D., Astwood J.D., Townsend R., Sampson H.A., Taylor S.L., and Fuchs R.L. Assessment of the allergenic potential of foods derived from genetically engineered crop plants. Crit. Rev. Food Sci. Nut. 36 Suppl. (1996) S165-S186
115. Milunsky A., and Alpert E. Results and benefits of a maternal serum alpha-fetoprotein screening program. JAMA 252 (1984) 1438-1442
116. Mirsalis J.C., and Butterworth B.E. Detection of unscheduled DNA synthesis in hepatocytes isolated from rats treated with genotoxic agents: an in vivo-in vitro assay for potential carcinogens and mutagens. Carcinogenesis 1 (1980) 621-625
117. Mittendorf R. Teratogen update: carcinogenesis and teratogenesis associated with exposure todiethylstilbestrol (DES) in utero. Teratology 51 (1995) 435-445
118. Morimoto K., and Koizumi A. Trihalomethanes induce sister chromatid exchanges in human lymphocytes in vitro and mouse bone marrow cells in vivo. Env. Res. 32 (1983) 72-79
119. Moss G.P., Gullick D.R., Cox P.A., Alexander C., Ingram M.J., Smart J.D., and Pugh W.J. Design, synthesis and characterization of captopril prodrugs for enhanced percutaneous absorption. J. Pharm. Pharmacol. 58 2 (2006) 167-177
120. NCI, 1978. Bioassay of 1,2-dibromoethane. National Cancer Institute. Technical Report No. 86. US Department of Health, Education, and Welfare. Bethesda, Maryland. NCI-CG-TR-86.
121. Nicholson J.K., Lindon J.C., and Holmes E. "Metabonomics": Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29 (1999) 1181-1189
122. NIEHS (National Institute of Environmental Health Sciences), 1997. Validation and regulatory acceptance of toxicological test methods: A report of the ad hoc Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). NIH publication No. 97-3981. NIEHS, Research Triangle Park, NC.
123. NRC. Science and Judgment in Risk Assessment (1994), National Research Council, National Academy Press, Washington, DC
124. NTP, 1982. Carcinogenicity bioassay of 1,2-dibromoethane in F344 and B6C3F1 mice (inhalation study). Technical Report No. 210. National Toxicology Program, US Department of Health and Human Services.
125. NTP, 2006. National Toxicology Program. Descriptions of NTP Study Types. Available from: .
126. OEHHA, 1999. Public Health Goals for Chemicals in Drinking Water. Methyl tertiary-butyl ether (MTBE). Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland/Sacramento.
127. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith S.C., Traubert K., Tracy R.P., and Vinicor F. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. Circulation 107 (2003) 499-511
128. Pietra G., Spencer K., and Shubik P. Response of newly born mice to a chemical carcinogen. Nature 183 4676 (1959) 1689
129. Renwick A. Toxicology databases and the concept of thresholds of toxicological concern as used by the JECFA for the safety evaluation of flavouring agents. Toxicol. Lett. 149 1-3 (2004) 223-234
130. Renwick A. Structure-based thresholds of toxicological concern-guidance for application to substances present at low levels in the diet. Toxicol. Appl. Pharmacol. 207 Suppl. 2 (2005) 585-591
131. Richard A.M., and Williams C.R. Public sources of mutagenicity and carcinogenicity data: use in structure-activity relationship models. In: Benigni R. (Ed). Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens (2003), CRC Press 145-173
132. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotien cholesterol levels in the predicition of first cardiovascual events. New Engl. J. Med. 347 (2002) 1557-1565
133. Robbiano L., Meretoe E., Migliazza-Morando A., Pastore P., and Brambilla G. Increased frequency of micronucleated kidney cells in rats exposed to halogenated anaesthetics. Mutat. Res. 413 1 (1998) 1-6
134. Robinson D.E., and MacDonald J.S. Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute. Toxicol. Pathol. 29 Suppl. (2001) 13-19
135. Rosenkranz H.S. SAR in the assessment of carcinogenesis: The MultiCASE approach. In: Benigni R. (Ed). Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens (2003), CRC Press, 2003 175-206
136. Rozman K.K., and Doull J. Dose and time as variables of toxicity. Toxicology 144 1-3 (2000) 169-178
137. San Agustin J., and Lim-Sylianco C.Y. Mutagenic and clastogenic effects of chloroform. Bull. Phil. Biochem. Soc. 1 (1978) 17-23 cited in US EPA, 1994
138. Scott A.E., Kashon M.L., Yucesoy B., Luster M.I., and Trinkle S.S. Insights into the quantitative relationship between sensitization and challenge for allergic contact dermatitis reactions. Toxicl. Appl. Pharmacol. 183 1 (2002) 66-70
139. Serafimova R., Walker J., and Mekenyan O. Androgen receptor binding affinity of pesticide "active" formulation ingredients: QSAR evaluation by COREPA method. SAR QSAR Environ. Res. 13 (2002) 127-134
140. Shelby M.D. The genetic toxicity of human carcinogens and its implications. Mutat. Res. 204 (1988) 3-15
141. Shelby M.D., and Zeiger E. Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests. Mutat. Res. 234 (1990) 257-261
142. Shi L.M., Fang H., Tong W., Wu J., Perkins R., Blair R.M., Branham W.S., Dial S.L., Moland C.L., and Sheehan D.M. QSAR models using a large diverse set of estrogens. J. Chem. Inf. Comput. Sci. 41 (2001) 186-195
143. Sonich-Mullin C., Fielder R., Wiltse J., Baetcke K., Dempsey J., Fenner-Crisp P., Grant D., Hartley M., Knaap A., Kroese D., Mangelsdorf I., Meek E., Rice J.M., and Younes M. International Programme on Chemical Safety., 2001. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 34 2 (2001) 146-152
144. Storer R.D., French J.E., Haseman J., Hajian G., LeGrand E.K., Long G.G., Mixson L.A., Ochoa R., Sagartz J.E., and Soper K.A. P53± hemizygous knockout mouse: overview of available data. Toxicol. Pathol. 29 Suppl. (2001) 30-50
145. Sturaro A., Parvoli G., Rella R., Bardati S., and Doretti L. Food contamination by diisopropylnaphthalenes from cardboard packages. Int. J. Food Sci. Tech. 29 (1994) 593-603
146. Summerfield W., and Cooper I. Investigation of migration from paper and board into food-development of methods for rapid testing. Food Addit. Contam. 18 1 (2001) 77-88
147. Tamano S., Hagiwara A., Kawabe M., Sano M., Tanaka H., Imaida K., Shirai T., and Ito N. Summary of test results of medium-term carcinogenesis bioassays targeting the liver or multi-organs. Toxicol. Pathol. 29 Suppl. (2001) 320-322
148. Tamaoki N. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis. Toxicol. Pathol. 29 Suppl. (2001) 81-89
149. Tan E.-L., and Hsie A.W. Mutagenicity and cytotoxicity of haloethanes as studied in the CHO/HGPRT system. Mutat. Res. 90 (1981) 183-191
150. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., et al. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236 4804 (1987) 933-941
151. Tennant R.W., Spalding J.W., Stasiewicz S., Caspary W.D., Mason J.M., and Resnick M.A. Comparative evaluation of genetic toxicity patterns of carcinogens and noncarcinogens: strategies for predictive use of short-term assays. Environ. Health Perspect 75 (1987) 87-95
152. Tennant R.W., Stasiewicz S., Eastin W.C., Mennear J.H., and Spalding J.W. The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model. Toxicol. Pathol. 29 Suppl. (2001) 51-59
153. Tyl R.W., Myers C.B., Marr M.C., Thomas B.F., Keimowitz A.R., Brine D.R., Veselica M.M., Fail P.A., Chang T.Y., Seely J.C., Joiner R.L., Butala J.H., Dimond S.S., Cagen S.Z., Shiotsuka R.N., Stropp G.D., and Waechter J.M. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol. Sci. 68 (2002) 121-146
154. UC, 1998. Health and Environmental Assessment of MTBE. Report to the Governor and Legislature of the State of California as Sponsored by SB 521. Five Volumes, 874pp. Available from: .
155. UK MAFF, 1999. UK Ministry of Agriculture, Fisheries and Food. Diisopropylnaphthalenes in food packaging made from recycled paper and board, Food Surveillance Information Sheet, Number 169.
156. 2u-globulin: Association with chemically-induced renal toxicity and neoplasia in the rat. EPA/625/3-91/019F, Washington, DC.
157. USEPA, 1998a. US Environmental Protection Agency. Guidelines for ecological risk assessment. Office of Research and Development. EPA/630/R-95/002F, Washington, DC.
158. USEPA, 1998b. US Environmental Protection Agency. Hazardous waste management system. Identification and listing of hazardous waste: land disposal restriction, organobromine production waste. 40 CFR, Part 261.
159. USEPA, 1998c. US Environmental Protection Agency. Assessment of thyroid follicular cell tumors. Risk Assessment Forum. Office of Research and Development. EPA/630/R-97/002. Washington, DC.
160. USEPA, 1998d. US Environmental Protection Agency. Health risk assessment/characterization of the drinking water disinfection byproduct chloroform. Office of Science and Technology, Office of Water, US Environmental Protection Agency, Washington, DC.
161. USEPA, 1998e. US Environmental Protection Agency. National Drinking Water Regulations: Disinfectants and Disinfection Byproducts; Final Rule. Federal Register 63 (241), 69389-69476, December 16.
162. USEPA, 1999a. US Environmental Protection Agency. 2,6-Diiospropylnaphthalene; Temporary exemption from the requirement of a tolerance. Federal Register 64(183):51245-51248, September 22.
163. USEPA, 1999b. US Environmental Protection Agency. Threshold of regulation policy-deciding whether a pesticide with a food use pattern needs a tolerance. October 18. Available from: .
164. USEPA, 2001. US Environmental Protection Agency. Toxicologic review of chloroform (CAS No.67-66-3). In support of summary information on the Integrated Risk Information System. EPA/635/R-01/001.
165. USEPA, 2003a. US Environmental Protection Agency. A Framework for a Computational Toxicology Research Program in ORD, Draft. Office of Research and Development, USEPA, Washington, DC. Available from: .
166. USEPA, 2003b. US Environmental Protection Agency. 2,6-Diiospropylnaphthalene; Temporary tolerances. Federal Register 68 (153), 47246-47353, August 8.
167. USEPA, 2005a. US Environmental Protection Agency. Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F, Washington, DC.
168. USEPA, 2005b. US Environmental Protection Agency. Notice of filing of a pesticide petition amendment to regulations for residues of the biochemical pesticide 2,6-diisopropylnaphthalene (2,6-DIPN) in or on potatoes. Federal Register 70 (236): 73234-73236. December 9.
169. USEPA, 2006. OPPTS Harmonized Test Guidelines. Series 870 Health Effects Test Guidelines-Final Guidelines. Available from: .
170. USFDA, 1995. US Food and Drug Administration. Food Additives; Threshold of regulation for substances used in food-contact articles. Federal Register 60(136): 36582-36596, July 17.
171. Usui T., Mutai M., Hisada S., Takoaka M., Soper K.A., McCullough B., and Alden C. CB6F1-rasH2 mouse: Overview of available data. Toxicol. Pathol. 29 Suppl. (2001) 90-108
172. van Kreijl C.F., McAnulty P.A., Beems R.B., Vynckier A., van Steeg H., Fransson-Steen R., Alden C.L., Forster R., van der Laan J.W., and Vandenberghe J. Xpa and Xpa/p53+/- knockout mice: overview of available data. Toxicol. Pathol. 29 Suppl. (2001) 117-127
173. van Steeg H., de Vries A., van Oostrom C.Th., van Benthem J., Beems R.B., and van Kreijl C.F. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models. Toxicol. Pathol. 29 Suppl. (2001) 109-116
174. Vinggaard A.M., Korner W., Lund K.H., Bolz U., and Petersen J.H. Identification and quantification of estrogenic compounds in recycled and virgin paper for household use as determined by in vitro yeast estrogen screen and chemical analysis. Chem. Res. Toxicol. 13 12 (2000) 1214-1222
175. Waalkes M.P., Ward J.M., Liu J., and Diwan B.A. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 186 1 (2003) 7-17
176. Wagner P.M., Nabholz J.V., and Kent R.J. The new chemicals process at the Environmental Protection Agency (EPA): structure-activity relationships for hazard identification and risk assessment. Toxicol. Lett. 79 (1995) 67-73
177. Wald N.J., Cuckle H., Brock J.H., Peto R., Polani P.E., and Wordford F.P. Maternal serum alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alphafetoprotein in relation to neural tube defects. Lancet 1 (1977) 1323-1332
178. Wallace K.B., Hausner E., Herman E., Holt G.D., MacGregor J.T., Metz A.L., Murphy E., Rosenblum I.Y., Sistare F.D., and York M.J. Serum troponins as biomarkers of drug-induced cardiac toxicity. Toxicol. Pathol. 32 (2004) 106-121
179. Waters M.D., Stack H.F., and Jackson M.A. Genetic toxicology data in the evaluation of potential human environmental carcinogens. Mutat. Res. 437 1 (1999) 21-49
180. Waters M.D., Stack H.F., and Jackson M.A. Short-term tests for defining mutagenic carcinogens. IARC Sci. Publ. 146 (1999) 499-536
181. Waters M., Boorman G., Bushel P., Cunningham M., Irwin R., Merrick A., Olden K., Paules R., Selkirk J., Stasiewicz S., Weis B., Van Houten B., Walker N., and Tennant R. System biology and the chemical effects in biological systems (CEBS) knowledge base. Environ. Health Persp. Toxicogenom. 111 1T (2003) 15-28
182. Weinberg, H.S., Krasner, S.W., Richardson, S.D., Thruston, A.D. Jr., 2002. The Occurrence of Disinfection By-Products (DBPs) of Health Concern in Drinking Water: Results of a Nationwide DBP Occurrence Study, EPA/600/R-02/068, US Environmental Protection Agency, Athens, GA.
183. WHO, 2005. World Health Organization. Concise International Chemical Assessment Document 66: 2,4,6-Tribromophenol and other simple brominated flame retardants, Geneva, Switzerland.
184. Wickner S., Maurizi M.R., and Gottesman S. Posttranslational quality control: folding, refolding, and degrading proteins. Science 286 (1999) 1888-1893
185. Williams, G.M. Iatropoulos, M.J., 2001. Principles of testing for carcinogenic activity. In: Principles and Methods in Toxicology. A Wallace Hayes, E. Fourth Edition, Taylor and Francis, Philadelphia, pp. 959-1000.
186. 1 mice from short-term, prechronic, and chronic studies of the NTP Carcinogenesis Bioassay Program. Environ. Mol. Mutagen. 36 (2000) 163-194
187. Woo Y.T., and Lai D. Mechanisms of action of chemical carcinogens and their role in structure-activity relationships (SAR) analysis and risk assessment. In: Benigni R. (Ed). Quantitative Structure-Activity Relationship (QSAR) Models of Mutagens and Carcinogens (2003), CRC Press 42-80
188. Woo Y.T., Lai D., McLain J.L., Manibusan M.K., and Dellarco V. Use of mechanism-based structure-activity relationships analysis in carcinogenic potential ranking for drinking water disinfection byproducts. Environ. Health Persp. 110 Suppl. 1 (2002) 75-87
189. Yamamoto S., Urano K., Koizumi H., Wakana S., Hioki K., Mitsumori K., Kurokawa Y., Hayashi Y., and Nomura T. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Environ. Health Perspect. 106 Suppl. 1 (1998) 57-69
190. Yamamoto S., Urano K., and Nomura T. Validation of transgenic mice harboring the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Toxicol. Lett. 102-103 473-8 (1998)
191. Yates III Y.R. Mass spectrometry. From genomics to proteomics. Trends Genet. 16 (2000) 5-8
192. Zeiger E., Haseman J.K., Shelby M.D., Margolin B.H., and Tennant R.W. Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen. 16 Suppl. 18 (1990) 1-14
193. Zeise L. Risk assessment of Genotoxic Carcinogens. In: Choy W.N. (Ed). Genetic Toxicology and Cancer Risk Assessment (2001), Marcel Dekker, New York 299-320